Correlation Between UnitedHealth Group and Cardiol Therapeutics

Can any of the company-specific risk be diversified away by investing in both UnitedHealth Group and Cardiol Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UnitedHealth Group and Cardiol Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between UnitedHealth Group CDR and Cardiol Therapeutics Class, you can compare the effects of market volatilities on UnitedHealth Group and Cardiol Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UnitedHealth Group with a short position of Cardiol Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of UnitedHealth Group and Cardiol Therapeutics.

Diversification Opportunities for UnitedHealth Group and Cardiol Therapeutics

0.65

Correlation Coefficient

UnitedHealth Group  Cardiol Therapeutics

Poor diversification

The 3 months correlation between UnitedHealth and Cardiol is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding UnitedHealth Group CDR and Cardiol Therapeutics Class in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardiol Therapeutics and UnitedHealth Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UnitedHealth Group CDR are associated (or correlated) with Cardiol Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardiol Therapeutics has no effect on the direction of UnitedHealth Group i.e., UnitedHealth Group and Cardiol Therapeutics go up and down completely randomly.

Pair Corralation between UnitedHealth Group and Cardiol Therapeutics

Assuming the 90 days trading horizon UnitedHealth Group CDR is expected to generate 0.41 times more return on investment than Cardiol Therapeutics. However, UnitedHealth Group CDR is 2.42 times less risky than Cardiol Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Cardiol Therapeutics Class is currently generating about -0.06 per unit of risk. If you would invest  2,420  in UnitedHealth Group CDR on December 26, 2024 and sell it today you would earn a total of  10.00  from holding UnitedHealth Group CDR or generate 0.41% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

UnitedHealth Group CDR  vs.  Cardiol Therapeutics Class

UnitedHealth Group CDR

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in UnitedHealth Group CDR are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, UnitedHealth Group is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Cardiol Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cardiol Therapeutics Class has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with UnitedHealth Group and Cardiol Therapeutics

The main advantage of trading using opposite UnitedHealth Group and Cardiol Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UnitedHealth Group position performs unexpectedly, Cardiol Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardiol Therapeutics will offset losses from the drop in Cardiol Therapeutics' long position.

The idea behind UnitedHealth Group CDR and Cardiol Therapeutics Class pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.